Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02568774
Other study ID # AcupPSOAB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2015
Est. completion date August 2018

Study information

Verified date October 2018
Source The University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effect of acupuncture on post-stroke overactive bladder symptoms. Participants will be put into groups randomly and compared. There are two groups: traditional acupuncture and usual care. The ratio of group allocation is 1:1.


Description:

Current practice in management of OAB is quite limited. Acupuncture, which is a major treatment modality of traditional Chinese medicine, has also claimed to have favourable therapeutic effect on OAB. Previous study found that acupuncture at the BL-33 point was effective for controlling the overactive bladder. Although acupuncture has been shown to be effective in treating OAB, there has been no randomized controlled trial examining the efficacy of acupuncture on patients with post-stroke. Given the high incidence of OAB in post-stroke patients, potentially effective alternative treatments should be investigated.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date August 2018
Est. primary completion date August 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Chinese aged 18 or above

2. Patient suffering from first ever stroke or recurrent stroke with no urinary symptom in previous episode(s);

3. Patient with classic symptoms, i.e. urgency, urinary frequency or urge incontinence and Overactive Bladder Symptom Score (OABSS) score =3 and the urgency item rated as at least 2-point;

4. Not taking any medication for OAB

5. Able to communicate

6. No current acupuncture or transcutaneous electrical nerve stimulation treatment

Exclusion Criteria:

1. Urinary retention with post-void urinary volume > 100ml;

2. Current urinary tract infection;

3. Preexisting history of OAB or bladder outlet obstruction or underactive bladder;

4. Significant cognitive impairment with MMSE < or =19;

5. Coexisting Alzheimer's disease, Parkinson's disease, spinal cord disorder or progressive neurological disease such as multiple sclerosis;

6. Active skin lesion or open wound over the needle placement areas;

7. Having valvular heart defects, severe cardiac diseases, or bleeding disorders,

8. Being fitted with any implanted electrical device such as pacemaker, defibrillator, or brain stimulation;

9. Pregnant;

10. Malignancies at the sites of selected acupoints;

11. Receiving acupuncture treatment 1 month before baseline.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Traditional Acupuncture
Treatment is based on the traditional Chinese medicine theory for treating overactive bladder. Qi-transforming function of bladder is regulated by experienced Chinese medicine practitioner.
Usual Care
Patients will receive conventional rehabilitation as usual, including standard physiotherapy, bladder training and general advise of fluid intake.

Locations

Country Name City State
China Shanghai TCM-INTEGRATED Hospital, Shanghai University of Traditional Chinese Medicine Shanghai
Hong Kong Tung Wah Eastern Hospital Hong Kong
Hong Kong Tung Wah Hospital Hong Kong

Sponsors (1)

Lead Sponsor Collaborator
The University of Hong Kong

Countries where clinical trial is conducted

China,  Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Other AE measured by open-ended questions open-ended questions about the experience of adverse events first week of treatment, second week of treatment, third week of treatment, 1-week posttreatment, 4-week posttreatment
Primary Overactive Bladder Symptom Scale (OABSS) four item questionnaire quantifies overactive bladder symptoms in a single score 1-week posttreatment
Secondary Number of incontinent episodes measured by bladder diary Record the frequency of day and night time voiding and incontinence episodes over 3 day periods 1-week posttreatment, 4-week posttreatment
Secondary Stroke Specific Quality of Life Scale (SS-QoLS) 12 items questionnaire consists of physical and psychosocial subscales: amount of help required completing a task, trouble experienced performing a task and functioning. 1-week posttreatment, 4-week posttreatment
Secondary Medication measured by bladder diary number of patients requested medication for OAB from bladder diary. 1-week posttreatment, 4-week posttreatment
See also
  Status Clinical Trial Phase
Recruiting NCT04578899 - "The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity" N/A
Active, not recruiting NCT03556891 - Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence N/A
Not yet recruiting NCT05977634 - Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder N/A
Completed NCT01955408 - Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment N/A
Recruiting NCT06201013 - Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children N/A
Recruiting NCT03727711 - TPTNS: Home vs Hospital Treatment for Overactive Bladder N/A
Completed NCT00768521 - A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) Phase 1
Completed NCT03625843 - Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing N/A
Completed NCT02211846 - A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder Phase 1
Completed NCT02857816 - PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB N/A
Completed NCT02835846 - Investigation of the Effect of the Female Urinary Microbiome on Incontinence Phase 4
Withdrawn NCT02320201 - Foot Neuromodulation for Overactive Bladder in Children N/A
Completed NCT02202031 - Controlling Urgency Through Relaxation Exercises N/A
Not yet recruiting NCT01423838 - Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder Phase 4
Not yet recruiting NCT01409512 - Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder N/A
Completed NCT01437670 - Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin N/A
Completed NCT01458197 - A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder. Phase 2
Withdrawn NCT01210859 - Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents N/A
Terminated NCT01758848 - Physical Therapy for Overactive Bladder N/A
Completed NCT01122563 - A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment N/A